Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948

Status:
Not yet recruiting

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Anemia in patients with very low, low or intermediate risk myelodysplastic syndromes (MDS)

Phase 2

University of Leipzig

Curis, Inc.